Fortis Malar Hospitals Share Price

BSE
FORTISMLR •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Fortis Malar Hospitals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
50.87% Fall from 52W High
-13.7
TTM PE Ratio
Low in industry
2
Price to Book Ratio
Low in industry
0.9
Dividend yield 1yr %
Market Leader
80.1
TTM PEG Ratio
0

Fortis Malar Hospitals Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Fortis Malar Hospitals Ltd Quarterly Revenue

Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
5.52 Cr
17.58 Cr
18.15 Cr
17.76 Cr
20.66 Cr

Fortis Malar Hospitals Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
65.96 Cr
92.59 Cr
93.57 Cr
77.5 Cr
123.06 Cr

Fortis Malar Hospitals Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
0.09 Cr
-0.06 Cr
54.05 Cr
-4 Cr
-1.79 Cr

Fortis Malar Hospitals Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
45.32 Cr
-15.48 Cr
-8.27 Cr
-7.87 Cr
-8.89 Cr

Fortis Malar Hospitals Ltd shareholding Pattern

Promoter
62.7%
Mutual Funds
0.1%
Public
37.2%
Promoter
62.7%
Mutual Funds
0.1%
Public
37.2%
Promoter
62.7%
Mutual Funds
0.1%
Public
37.2%
Promoter
62.7%
Mutual Funds
0.1%
Public
37.2%
Promoter
62.7%
Mutual Funds
0.1%
Public
37.2%
Promoter
62.7%
Mutual Funds
0.1%
Public
37.2%
Foreign Institutions
0.8%
Foreign Institutions
0.8%
Foreign Institutions
0.8%

Fortis Malar Hospitals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
53.10
10Day EMA
53.30
12Day EMA
53.40
20Day EMA
53.90
26Day EMA
54.30
50Day EMA
56.00
100Day EMA
58.50
200Day EMA
60.20
5Day SMA
52.80
10Day SMA
53.30
20Day SMA
53.50
30Day SMA
54.40
50Day SMA
56.30
100Day SMA
59.60
150Day SMA
64.00
200Day SMA
61.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
9689 Rs
14527 Rs
Week Rs
9677 Rs
12836 Rs
Month Rs
18725 Rs
24276 Rs
Resistance & Support
53.15
Pivot
Resistance
First Resistance
53.98
Second Resistance
54.94
Third Resistance
55.77
Support
First Support
52.19
Second support
51.36
Third Support
50.40
Relative Strength Index
43.13
Money Flow Index
35.86
MACD
-0.91
MACD Signal
-1.03
Average True Range
1.97
Average Directional Index
25.90
Rate of Change (21)
-5.24
Rate of Change (125)
-21.19

Fortis Malar Hospitals Ltd Company background

Founded in: 1989
Fortis Malar Hospital Limited (formerly known as Malar Hospital Limited) was established in April 13, 1989 to set up, manage and operate a multispecialty hospital. The Hospital was acquired by Fortis Group in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multispeciality healthcare services. With a total bedstrength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal MedicineAll the above departments are fully became operational under phase I of the project. The second phase of the project envisages enhacement of the number of beds from 100 to 250 beds at an cost of Rs.2120 lacs. To part the project the company came into rights issues during 1995. The Hospital have started performing Cardio Thoracic surgeries with effect from 13102003. Dr.K M Cherian is leading this cardio Thoracic department. He has won several awards and honors including Padmashree award from the Government. Dr.K M Cherian has conducted around 26,200 cardio thoracic cases including infant heart surgery, heart transplants, paediatric heart transplants and heart and lung transplants. This type of surgery will bring more revenue to the hospital in the comming years. With Dr.K M Cherian at command of cardio thoracic team, the future looks bright.On 7th September 2007 the Company and the Promoters of the Company entered into a Loan, Share Subscription and Share Purchase Agreement (LSSSPA) with International Hospital Ltd, a wholly owned subsidiary of Fortis Healthcare Limited and Oscar Investments Ltd (Acquirer) for the sale of 39,00,000 Equity Shares by the Promoters of the Company and for availing a loan of Rs 14 crores fromthe Acquirers, convertible into Equity Shares of the Company. Further, the Acquirer Companies acquired 39,00,000 Equity Shares from the Promoters of the Companies on 18th February 2008 which together with their existing holding, constituted 62.17% of the Share Capital of the Company. The Management and Control of Affairs of Company is now with the Acquirers, who consequently shall act as Promoters of the Company.On, 7th July, 2009, Company incorporated a wholly owned subsidiary viz. Malar Stars Medicare Limited.The Board of Directors of Company on August 19, 2016 approved a Composite Scheme of Arrangement and Amalgamation between Company, Fortis Healthcare Limited (FHL), SRL Limited (SRL) and their respective Shareholders and Creditors for (i) the transfer of the undertaking, business and operations of the Company as a going concern, by way of slump sale, from the Company to FHL, (ii) the transfer by way of a demerger of the undertakings, business, activities and operations of FHL, pertaining to diagnostics business of FHL (Demerged Undertaking) to Company, and consequent issue of Equity Shares by Company to Shareholders of FHL (iii) amalgamation of all the undertakings and entire business of SRL with Company and dissolution of SRL without winding up the consequent issue of equity shares by Company to the Shareholders of SRL and the cancellation of equity shares of SRL held by Company and various other matters consequential or otherwise integrally connected therewith. Further, National Company Law Tribunal, Chandigarh, vide its order dated June 15, 2018 approved the scheme as withdrawn and accordingly, as on date, the Scheme was terminated by Company, SRL and FHL.Pursuant to execution of Share Subscription Agreement on July 13, 2018 (SSA), Northern TK Venture Pte Ltd (NTK or the Acquirer), a wholly owned subsidiary of IHH Berhard, subscribed to 235,294,117 new equity shares of Fortis Healthcare Limited (FHL) with a face value of Rs 10 each, constituting approximately 31.1% of the total voting equity share capital of FHL on a fully diluted basis for a total consideration of Rs 4,000 crore and FHL issued and allotted the Subscription Shares by way of preferential allotment in accordance with the terms of the SSA. As a consequence of Subscription, the Acquirer together with IHH Healthcare Berhad (PAC 1) and Parkway Pantai Limited (PAC 2), made a mandatory Open Offer, by filing a Public Announcement dated July 13, 2018. The Subscription completed in accordance with the terms of the SSA on November 13, 2018 and NTK became the controlling shareholder of FHL.
Read More

Fortis Malar Hospitals Ltd FAQs

The Mutual Fund Shareholding was 0.07% at the end of .

You can easily buy Fortis Malar Hospitals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -